Schedule-dependent Combined Sensitivity Testing of Anti-cancer Agents in Human Gastric Carcinoma Cell Lines

Author： Murashima N Gochi A Kenmotsu M Hamazaki K Funaki M Ohtsuka S Tanaka N

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.29, Iss.3, 2001-05, pp. : 189-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing

Current Medicinal Chemistry, Vol. 20, Iss. 10, 2013-04 ,pp. : 1203-1217

Bentham Science Publishers

Access to resources Recommend Favorite

Plant Anti-cancer Agents and their Biotechnological Production in Plant Cell Biofactories

Current Medicinal Chemistry, Vol. 23, Iss. 39, 2016-12 ,pp. : 4418-4441

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines

By Collins D. Crown J. O’Donovan N. Devery A. O’Sullivan F. O’Driscoll L. Clynes M. O’Connor R.

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 433-444

Springer Publishing Company

Access to resources Recommend Favorite

TXNL1 Induces Apoptosis in Cisplatin Resistant Human Gastric Cancer Cell Lines

Current Cancer Drug Targets, Vol. 14, Iss. 9, 2014-11 ,pp. : 850-859

Bentham Science Publishers

Access to resources Recommend Favorite

Rebeccamycin analogues as anti-cancer agents

By Prudhomme M.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 2, 2003-02 ,pp. : 123-140

Elsevier

Access to resources Recommend Favorite